Deltex Medical Receives Innovative Technology Contract From Major US Healthcare Consultancy

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has received an Innovative Technology contract from Vizient, Inc., the largest member-driven healthcare performance improvement company in the United States. The contract was based on the recommendation of hospital experts in haemodynamics who serve on one of Vizient’s member-led councils. Innovative Technology contracts are reserved for technologies that demonstrate an ability to
significantly enhance clinical care and patient safety, whilst improving an organisation’s care delivery and business model.

Since 2003, nearly 2,200 new and innovative products and technologies have been submitted through the Vizient Innovative Technology Program. Vizient works with member-led councils and task forces to identify and review potentially innovative products.

Full release here.